financetom
Business
financetom
/
Business
/
NeuroPace to End Stereo EEG Distribution Accord; 2025 Revenue Guidance Affirmed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NeuroPace to End Stereo EEG Distribution Accord; 2025 Revenue Guidance Affirmed
Apr 2, 2025 2:24 PM

05:12 PM EDT, 04/02/2025 (MT Newswires) -- NeuroPace ( NPCE ) plans to end its distribution agreement with DIXI Medical for stereo EEG products to focus on its portfolio for differentiated responsive neurostimulation systems.

The distribution agreement will wind down in Q4 and into the following quarter, NeuroPace ( NPCE ) said Wednesday in a statement.

NeuroPace ( NPCE ) maintained its 2025 revenue guidance along with long-range expectations of at least a 20% compound annual growth rate and cash flow breakeven by the end of 2027.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved